NCT04815109View on ClinicalTrials.gov

Prospective Electroencephalography Evaluation of Sedation in COVID-19

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

June 30, 2022

Conditions
Conscious SedationPathologic ProcessesElectroencephalogramAcute Respiratory Distress SyndromeCorona Virus Infection
Interventions
OTHER

Encephalography measurement

Encephalography measurement and partially aggravated sedation.

Trial Locations (1)

60590

University Hospital Frankfurt, Frankfurt am Main

Sponsors

Lead Sponsor

Goethe University
All Listed Sponsors
lead

Goethe University

OTHER

NCT04815109 - Prospective Electroencephalography Evaluation of Sedation in COVID-19 | Biotech Hunter | Biotech Hunter